Four experts will discuss the management for nonalcoholic fatty liver disease (NAFLD) and its progression to nonalcoholic steatohepatitis (NASH) during Tuesday’s AASLD Clinical Symposium Identification and Management of Patients with NAFLD/NASH.
What you learned last year about the treatment of IBD is already out of date.
During Tuesday’s SSAT Joint Symposium with the International Society for Digestive Surgery, five experts will examine the appropriate use of minimally invasive surgery in managing cancers of the gastrointestinal tract. The two-hour morning symposium is titled Minimally Invasive Frontier in GI Surgery.
The 21st annual ASGE Video Plenary session on Tuesday will feature a peer-reviewed selection of videos showcasing state-of-the-art endoscopic techniques and unusual cases from around the world. New this year, nine videos will receive “Best of Best” awards and the highest scoring video will be presented a special award.
The management of hepatocellular cancer (HCC) saw meaningful advances in 2016 with the introduction of two compounds, regorafenib and lenvatinib, for patients with advanced HCC.
Have an idea for a new medical device, technology or service? Getting it to market is a complex, time-consuming process that requires analytical and management skills, great communication, collaboration and leadership, according to Virender Sharma, MD, AGAF, who shared lessons he’s learned as a physician innovator on Saturday at DDW® during a session sponsored by the AGA Center for GI Innovation and Technology.
Caring for patients with IBD requires a multidisciplinary approach. So the organizers of Tuesday’s DDW® Clinical Symposium Endoscopic and Surgical Principles in IBD set out to create a multidisciplinary educational program. The 90-minute symposium is jointly sponsored by AGA, ASGE and SSAT.
‘Your life’s work should be fun. If it’s nothing more than a job, it’s time to find your passion.
That was the message from SSAT President Nathaniel J. Soper, MD, who recounted his professional journey Sunday morning at DDW® during the annual SSAT Presidential Address.
Four experts will discuss key considerations when making surgical decisions for cirrhotic patients during Tuesday’s DDW® Clinical Symposium, Cirrhosis and Surgery: Identifying and Managing, which
GERD is extremely common, with up to one in four American adults experiencing symptoms at least once a month. The mainstay of treatment is proton
